Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501781017 | Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3678565014 | Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Ephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Ephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing guaifenesin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Smooth muscle relaxant | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Guaifenesin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Bronchodilator | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Musculoskeletal system agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing ephedrine and guaifenesin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing ephedrine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Ephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Ephedrine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Guaifenesin | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing ephedrine and guaifenesin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Ephedrine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing only ephedrine and guaifenesin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Plays role | Expectorant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing sympathomimetic | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets